Filing Details

Accession Number:
0001214659-21-000341
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-08 19:57:00
Reporting Period:
2021-01-06
Accepted Time:
2021-01-08 19:57:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405637 S Vickie Reed C/O Mirati Therapeutics
9393 Towne Centre Drive Suite 200
San Diego CA 92121
Svp, Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-06 11 $215.70 8,239 No 4 S Direct
Common Stock Disposition 2021-01-06 527 $210.28 7,712 No 4 S Direct
Common Stock Disposition 2021-01-07 241 $216.33 7,471 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.
  2. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 6, 2020.
  3. This transaction was executed in multiple trades at prices ranging from $215.657 to $216.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.